APA (7th ed.) Citation

Steffens, P., Weiss, D., Perez, A., Appel, M., Weber, P., Weiss, C., . . . Johannsen, J. (2024). Cognitive function in SMA patients with 2 or 3 SMN2 copies treated with SMN-modifying or gene addition therapy during the first year of life. European journal of paediatric neurology, 51, . https://doi.org/10.1016/j.ejpn.2024.05.002

Chicago Style (17th ed.) Citation

Steffens, Paula, et al. "Cognitive Function in SMA Patients with 2 or 3 SMN2 Copies Treated with SMN-modifying or Gene Addition Therapy During the First Year of Life." European Journal of Paediatric Neurology 51 (2024). https://doi.org/10.1016/j.ejpn.2024.05.002.

MLA (9th ed.) Citation

Steffens, Paula, et al. "Cognitive Function in SMA Patients with 2 or 3 SMN2 Copies Treated with SMN-modifying or Gene Addition Therapy During the First Year of Life." European Journal of Paediatric Neurology, vol. 51, 2024, https://doi.org/10.1016/j.ejpn.2024.05.002.